Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
TrimRx ensures every provider is licensed, experienced, and focused on patient success
From 2030 to 2035, the market is forecast to grow from USD 39,528 million to USD 65,364 million, adding another USD 25836.0 million, which constitutes 45.2% of the overall ten-year expansion
work with insurance
If a patient misses dose tolerance because of GI symptoms, the drug cannot be cleared quickly
Retatrutide Blood Tests & Monitoring Retatrutide is a GLP-1/GIP/glucagon receptor agonist research compound
US$ 28.37
US$ 21.93
US$ 23.63
US$ 22.56
US$ 25.41
US$ 26.41
US$ 28.51
